information recap last 10 months IMUN
news summary last 10 months IMUN
Wednesday January 16, 2019
Immune Therapeutics Inc, Provides Scientific and also Update and Links To Peer Review Publications
https://www.dovepress.com/the-novel-mechanism-of-anticancer-effect-on-gastric-cancer-through-ind-peer-reviewed-article-CMAR
Immune Therapeutics invites Kevin Phelps to Board of Directors
Wednesday January 9, 2019
Kevin Phelps is a financing and also business growth professional who has actually spent his career identifying, pleasing and handling the functional needs of a large range of business. With more than 25 years of broad, specialist business experience, Mr. Phelps has actually held senior management placements, effectively raising capital for startup firms, handling economic companies and also establishing new organisations via innovation, calculated partnerships and procurement task
“I am thrilled to sign up with Immune Therapeutics’ Board of Directors and also to add my experience in business endeavors. Immune Therapeutics has terrific possible, and I intend to help in maximizing this prospective to bring extraordinary ROI for investors,” stated Mr. Phelps.s.
https://www.immunetherapeutics.com/2019/01/immune-therapeutics-welcomes-kevin-phelps-board-directors/
Thursday December 13, 2018
Research Study on Lodonal (“LDN”) for HIV-related GI issues, as well as Inflammation included in A&U Magazine
The author assumed that: “Separately, and collectively, these studies show that Naltrexone, in its various types,” (Lodonal ™/ LDN) “… is a unique and also functional treatment that holds potential for several uses in HIV illness and various other problems. PLWHAs struggling to recuperate immune feature and also those addicted to opiates as well as alcohol might highly profit from its usage as well as standards to assist these key populaces of PLWHAs ought to be thought about to assist maintain viral suppression as well as therapy retention.”
https://www.immunetherapeutics.com/2018/12/research-lodonal-ldn-hiv-related-gi-complications-inflammation-featured-au-magazine/
Thursday September 6, 2018
Immune Therapeutics Welcomes AMB Jack Brewer to the Board of Directors
Mr. Brewer, creator as well as CEO of The Brewer Group Companies (TBG) and also a former wealth supervisor with Merrill Lynch, presently manages The Brewer Group’s personal portfolio, which concentrates on effect investing. Mr. Brewer likewise acts as a constant service contributor on Fox Business and appears on worldwide as well as national media electrical outlets such as CNN, CNN International, CNBC, MSNBC, CNBC, CCTV and Sky News. Mr. Brewer is a previous football safety who played professionally in the National Football League, where he was a captain on the Minnesota Vikings, New York Giants and the Philadelphia Eagles. Mr. Brewer presently coaches and aids several professional athletes as they shift from sports to organisation. Brewer made his Bachelor of Science (2001) and also his Masters in Sport Management (2002) from the University of Minnesota, all while playing Division I football.
In addition, he has completed Executive Business Programs at Harvard School of Business (2005) and also the Wharton School of Business (2006 ), and is currently pursuing his Masters in International Affairs from Colombia University. Brewer is currently completing the Executive MBA program at the University of Miami where he is leading Brewer Sports International’s education and learning program to be the biggest post-secondary level program in specialist sporting activities, having actually graduated over 40 current and also former specialist athletes with EMBA levels in its first graduating class.
“I’m very thrilled regarding the possibility to add my experience in entrepreneurial endeavors to Immune Therapeutics throughout this period of appointing new management skill,” specified Mr. Brewer. Mr. Brewer even more stated that, “Through its recent pivot, Immune Therapeutics exhibits business and also social effect that I value, and also I believe I can better assist in opening their possibility.”
Wednesday September 5, 2018
Immune Therapeutics Labeled as a Pioneer in Forbes Article Discussing Booming Pet Care Industry
The short article, which likewise includes passages from an interview with the Company’s CEO, Noreen Griffin, identifies Immune Therapeutics as a ‘pioneering biopharmaceutical company that acknowledged the large potential in the growing animal health and wellness market as well as has actually presented a partnership to touch into it’ (describing the Company’s recent 10% purchase of Cytocom, Inc. that included special civil liberties to Lodonal ™ as well as Met-Enkephline for the therapy of family pets in the United States).
Renown HIV expert Dr. Gary Blick Joins Immune Therapeutics Advisory Board
He headed his private technique in Stanford Connecticut for over 30 years, treating HIV patients in the very early days of the U.S. HIV epidemic. Dr. Blick is Founder of Health Care Advocates International and BEAT AIDS Project Zimbabwe where he serviced over 8600 individuals. He has authored over 40 publications as well as looked after various HIV clinical tests.
“I am honored and also very amazing to join Immune Therapeutics’ SAB. I have adhered to the research on LDN from the early days of the HIV epidemic with its usage on the African continent, having actually examined the clinical information on its use in Nigeria for discussion at the 2015 International Conference on AIDS and also STIs in Africa (ICASA) kept in Zimbabwe. As an unique immunomodulatory representative that is generally well-tolerated in all individual kinds, its prospective advantages for individuals living with HIV/AIDS require to be completely explored, specifically in those with stomach co-morbidities, such as Crohn’s enterocolitis,” stated Dr. Blick.
Tuesday August 7, 2018
Immune Therapeutics Adds Former United States Assistant Surgeon General Dr. Roscoe Moore to Board of Directors
https://www.immunetherapeutics.com/2018/08/immune-therapeutics-adds-former-united-states-assistant-surgeon-general-dr-roscoe-moore-board-directors/
Dr. Moore stated, “I’m extremely thrilled concerning the potential of IMUN’s advancement of Lodonal ™ (reduced dosage naltrexone) for the variety of immune-suppressive inflammatory problems that are converging the series of co-morbidities which aggravate illness development in clients with HIV, cancer cells and various other significant immune characterizing diseases. The presentation of benefits of immuno-metabolomic delegating therapies like Lodonal ™ to abate the hyperactivation of critical cellular expression is placed to be an appealing breakthrough adhering to aggregate information presented at AIDS 2018.”
The promising CD4 recovery data was also attended to in a recent HIV Plus publication short article discussing the differences in resolving ignored GI issues in HIV patients. Effective therapies, not associated with major damaging occasions, are required to minimize these problems that are linked with bad antiretroviral medicine adherence, elevation of inflammatory cytokines and unfavorable effect immune reconstitution.
Dr. Moore was a career police officer within the Commissioned Corps of the United States Public Health Service (USPHS) as well as Assistant United States Surgeon General (Rear Admiral, USPHS) within the Immediate Office of the Secretary, Department of Health as well as Human Services (HHS). He operated as Principal Liaison between the HHS and the ministries of health of African countries for the growth of framework for preventative health and wellness requirements and also was integrally included in the development of the President’s Emergency Program for AIDS Relief (PEPFAR) program under President George W. Bush, a program which is attributed with turning the tide of the international AIDS pandemic. He was picked as Chief Veterinary Medical Officer, USPHS, by Surgeon General C. Everett Koop, and was the Chief Epidemiologist with the Center for Devices and also Radiological Health for the FDA.
Dr. Moore offered as an Epidemic Intelligence Service Officer with the U.S. Centers for Disease Control as well as Prevention (CDC) and as the ranking veterinarian throughout all uniformed services, consisting of the armed pressures. Dr. Moore has actually conducted medical study on transmittable conditions including Venezuelan horse encephalitis, tuberculosis, listeriosis, hiv/aids, malaria, as well as psittacosis.
Immune Therapeutics Inc Announces Publication of Peer Reviewed Scientific Paper Describing Low-Dose Naltrexone (LDN): A Promising Treatment in Immune-Related Diseases as well as Cancer Therapies
ORLANDO, Fla., July 25, 2018 (GLOBE NEWSWIRE)– through OTC PR WIRE– Immune Therapeutics, Inc. (OTCQB: IMUN) (“Immune” “IMUN” or the “Company”), a clinical late phase biopharmaceutical business concentrated on the growth of treatments for the therapy of autoimmune diseases, inflammatory conditions, cancer and also HIV/AIDS, is happy to introduce the publication of a peer evaluated clinical paper describing LDN as an appealing therapy in immune relevant disease and also cancer cells therapies as recognized in the lab by Dr. Fengping Shan, IMUN’s Chief Scientific Officer.
Thursday July 19, 2018
Research study on Lodonal for HIV relevant GI difficulties featured in Plus Magazine
ORLANDO, Fla., July 19, 2018 (GLOBE NEWSWIRE)– through OTC Public Relations WIRE– Immune Therapeutics, Inc. (OTCQB: IMUN) (“Immune” “IMUN” or the “Company”), a clinical late stage biopharmaceutical company concentrated on the growth of treatments for the therapy of autoimmune conditions, inflammatory diseases, cancer cells and also HIV/AIDS revealed today that their lead therapy, Lodonal (LDN), was included in a short article published in Plus Magazine: https://www.hivplusmag.com/i-am-warrior/2018/7/12/will-needs-long-term-survivors-be-heard.